[1]
Sukhodolya, S. et al. 2015. Evidence of use: A selective COX-2 inhibitor in the treatment of experimental chronic pancreatitis induced by Dibutyltin dichloride. Current Issues in Pharmacy and Medical Sciences. 28, 2 (Jul. 2015), 131–135. DOI:https://doi.org/10.1515/cipms-2015-0059.